Journal
BIOCHEMICAL JOURNAL
Volume 461, Issue -, Pages 15-32Publisher
PORTLAND PRESS LTD
DOI: 10.1042/BJ20131587
Keywords
co-activator; co-repressor; promoter; transcription; Wilms' tumour 1 (WT1); zinc finger
Categories
Funding
- NIGMS NIH HHS [R01 GM098609] Funding Source: Medline
Ask authors/readers for more resources
The WT1 (Wilms' tumour 1) gene encodes a zinc finger transcription factor and RNA-binding protein that direct the development of several organs and tissues. WT1 manifests both tumour suppressor and oncogenic activities, but the reasons behind these opposing functions are still not clear. As a transcriptional regulator, WT1 can either activate or repress numerous target genes resulting in disparate biological effects such as growth, differentiation and apoptosis. The complex nature of WT1 is exemplified by a plethora of isoforms, post-translational modifications and multiple binding partners. How WT1 achieves specificity to regulate a large number of target genes involved in diverse physiological processes is the focus of the present review. We discuss the Wealth of the growing molecular information that defines our current understanding of the versatility and utility of WT1 as a master regulator of organ development, a tumour suppressor and an oncogene.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available